Research programme: cyclo-oxygenase-2 inhibitors - Roche Bioscience

Drug Profile

Research programme: cyclo-oxygenase-2 inhibitors - Roche Bioscience

Alternative Names: Research programme: COX-2 inhibitors - Roche

Latest Information Update: 08 Nov 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Roche Palo Alto LLC
  • Class
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 08 Nov 2006 Discontinued - Preclinical for Inflammation in USA (unspecified route)
  • 14 Aug 2001 No-Development-Reported for Inflammation in USA (Unknown route)
  • 12 Aug 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top